Bristol Myers Squibb Board Elects Two New Independent Directors
NEC member Bristol Myers Squibb recently announced that its Board of Directors has elected two new members.. Ms. Paula A. Price and Mr. Derica W. Rice will join the board in early September.
Ms. Price has over 50 years of experience in finance and operations and most recently served as executive vice president, chief financial officer, and now advisor for Macy’s Incorporated. Prior to that, she was a senior lecturer at Harvard Business School in Accounting and Management. She has held senior positions at JPMorgan Chase, Prudential Financial, Diageo, and Kraft Foods.
Ms. Price commented, “I am delighted to join the Board of Bristol Myers Squibb at this important moment in its history. I am drawn to the company because of its transformative science and the potential of its portfolio to continue delivering breakthrough medicines. I welcome the opportunity to help the company deliver on its promise to patients through its leading science and commercial capabilities.”
Mr. Rice has served as executive vice president of global services and CFO for Eli Lilly and Company for 27 years. During his time there, Mr. Rice helped spark the company’s innovation strategies and served in senior finance and operations roles. He currently serves on the Walt Disney Board of Directors and previously served on the Board of Directors of Target Corporation.
Mr. Rice commented, “I admire Bristol Myers Squibb as a leader and innovator, and am very pleased to join the Board. I look forward to working alongside the rest of the Board to build on the company’s legacy and substantial progress to help more patients.”
The New England Council congratulates Ms. Price and Mr. Rice on their new positions. Read more from the Bristol Myers Squibb press release.